In Vitro Selection of Specific DNA Aptamers Against the Anti-Coagulant Dabigatran Etexilate

Dabigatran Etexilate (PRADAXA) is a new oral anticoagulant increasingly used for a number of blood thrombosis conditions, prevention of strokes and systemic emboli among patients with atrial fibrillation. It provides safe and adequate anticoagulation for prevention and treatment of thrombus in sever...

Descripción completa

Detalles Bibliográficos
Autores principales: Aljohani, Maher M., Chinnappan, Raja, Eissa, Shimaa, Alsager, Omar A., Weber, Karina, Cialla-May, Dana, Popp, Jürgen, Zourob, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125329/
https://www.ncbi.nlm.nih.gov/pubmed/30185972
http://dx.doi.org/10.1038/s41598-018-31327-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125329/
https://www.ncbi.nlm.nih.gov/pubmed/30185972
http://dx.doi.org/10.1038/s41598-018-31327-3

Ejemplares similares